| Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease DE Niewoehner, ML Erbland, RH Deupree, D Collins, NJ Gross, RW Light, ... New England Journal of Medicine 340 (25), 1941-1947, 1999 | 1337 | 1999 |
| Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology MB Dolovich, RC Ahrens, DR Hess, P Anderson, R Dhand, JL Rau, ... Chest 127 (1), 335-371, 2005 | 1075 | 2005 |
| Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial DP Tashkin, R Kanner, W Bailey, S Buist, P Anderson, MA Nides, ... The Lancet 357 (9268), 1571-1575, 2001 | 603 | 2001 |
| A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial RC Bone, RA Balk, AM Fein, TM Perl, RP Wenzel, HD Reines, ... Critical care medicine 23 (6), 994-1006, 1995 | 453 | 1995 |
| Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III … E Abraham, PF Laterre, J Garbino, S Pingleton, T Butler, T Dugernier, ... Critical care medicine 29 (3), 503-510, 2001 | 403 | 2001 |
| Evaluation of left atrial lesions after initial and repeat atrial fibrillation ablation: lessons learned from delayed-enhancement MRI in repeat ablation procedures TJ Badger, M Daccarett, NW Akoum, YA Adjei-Poku, NS Burgon, ... Circulation: Arrhythmia and Electrophysiology 3 (3), 249-259, 2010 | 266 | 2010 |
| History of aerosol therapy: liquid nebulization to MDIs to DPIs PJ Anderson Respiratory care 50 (9), 1139-1150, 2005 | 202 | 2005 |
| Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease PJ Anderson, JD Wilson, FC Hiller Chest 97 (5), 1115-1120, 1990 | 182 | 1990 |
| Use of Respimat® Soft Mist™ Inhaler in COPD patients P Anderson International journal of chronic obstructive pulmonary disease 1 (3), 251-259, 2006 | 171 | 2006 |
| Global left atrial strain correlates with CHADS2 risk score in patients with atrial fibrillation SK Saha, PL Anderson, G Caracciolo, A Kiotsekoglou, S Wilansky, ... Journal of the American Society of Echocardiography 24 (5), 506-512, 2011 | 149 | 2011 |
| American College of Asthma, Allergy, and Immunology. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American … MB Dolovich, RC Ahrens, DR Hess, P Anderson, R Dhand, JL Rau, ... Allergy, and Immunology. Chest 127 (1), 335-371, 2005 | 149 | 2005 |
| Effect of cystic fibrosis on inhaled aerosol boluses 1–3 PJ Anderson, JD Blanchard, JD Brain, HA Feldman, JJ Mcnamara, ... Am. Rev. Respir. Dis 140, 1317-1324, 1989 | 143 | 1989 |
| Patient preference for and satisfaction with inhaler devices P Anderson European Respiratory Review 14 (96), 109-116, 2005 | 126 | 2005 |
| Consensus statement: aerosols and delivery devices. American Association for Respiratory Care MA Dolovich, NR MacIntyre, PJ Anderson, CA Camargo Jr, N Chew, ... Respiratory care 45 (6), 589-596, 2000 | 102 | 2000 |
| Delivery options and devices for aerosolized therapeutics PJ Anderson Chest 120 (3), 89S-93S, 2001 | 82 | 2001 |
| Respiratory drug delivery: essential theory and practice S Newman, P Anderson Respiratory Drug Delivery Online, 2009 | 77 | 2009 |
| Randomized, double‐blind, placebo‐controlled, dose‐escalating study of aerosolized interferon gamma‐1b in patients with mild to moderate cystic fibrosis lung disease RB Moss, N Mayer‐Hamblett, J Wagener, C Daines, K Hale, R Ahrens, ... Pediatric pulmonology 39 (3), 209-218, 2005 | 74 | 2005 |
| Particle size distribution of mainstream tobacco and marijuana smoke PJ Anderson, JD Wilson, FC Hiller Am Rev Respir Dis 140, 202-205, 1989 | 72 | 1989 |
| Aerosol bolus dispersion and convective mixing in human and dog lungs and physical models FS Rosenthal, JD Blanchard, PJ Anderson Journal of Applied Physiology 73 (3), 862-873, 1992 | 63 | 1992 |
| Forced expiratory volume in 1 second variability helps identify patients with cystic fibrosis at risk of greater loss of lung function WJ Morgan, DR Vandevanter, DJ Pasta, AJ Foreman, JS Wagener, ... The Journal of pediatrics 169, 116-121. e2, 2016 | 59 | 2016 |